These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 19026697)

  • 1. Uncoupling between Ig somatic hypermutation and oncogene mutation in mouse lymphoma.
    Vincent C; Truffinet V; Fiancette R; Petit B; Cogné N; Cogné M; Denizot Y
    Biochim Biophys Acta; 2009 Feb; 1793(2):418-26. PubMed ID: 19026697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular genetic features of sporadic Burkitt's lymphoma in children].
    Yang WP; Huang H; Gong LP; Wu Y; Xu HY; Zou Y; Lü BB; Zhong HS; Deng QQ; Xiao Q; Zeng ST; Zhu CD
    Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):819-24. PubMed ID: 21215097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ongoing hypermutation in the Ig V(D)J gene segments and c-myc proto-oncogene of an AIDS lymphoma segregates with neoplastic B cells at different sites: implications for clonal evolution.
    Ikematsu H; Cerutti A; Zan H; Knowles DM; Ikematsu W; Casali P
    Hum Immunol; 2000 Dec; 61(12):1242-53. PubMed ID: 11163079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 3' IgH locus control region is sufficient to deregulate a c-myc transgene and promote mature B cell malignancies with a predominant Burkitt-like phenotype.
    Truffinet V; Pinaud E; Cogné N; Petit B; Guglielmi L; Cogné M; Denizot Y
    J Immunol; 2007 Nov; 179(9):6033-42. PubMed ID: 17947677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The c-MYC allele that is translocated into the IgH locus undergoes constitutive hypermutation in a Burkitt's lymphoma line.
    Bemark M; Neuberger MS
    Oncogene; 2000 Jul; 19(30):3404-10. PubMed ID: 10918597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for AID in chromosome translocations between c-myc and the IgH variable region.
    Dorsett Y; Robbiani DF; Jankovic M; Reina-San-Martin B; Eisenreich TR; Nussenzweig MC
    J Exp Med; 2007 Sep; 204(9):2225-32. PubMed ID: 17724134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A p53 defect sensitizes various stages of B cell development to lymphomagenesis in mice carrying an IgH 3' regulatory region-driven c-myc transgene.
    Fiancette R; Rouaud P; Vincent-Fabert C; Laffleur B; Magnone V; Cogné M; Denizot Y
    J Immunol; 2011 Dec; 187(11):5772-82. PubMed ID: 22039300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant somatic hypermutation in multiple subtypes of AIDS-associated non-Hodgkin lymphoma.
    Gaidano G; Pasqualucci L; Capello D; Berra E; Deambrogi C; Rossi D; Maria Larocca L; Gloghini A; Carbone A; Dalla-Favera R
    Blood; 2003 Sep; 102(5):1833-41. PubMed ID: 12714522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ongoing somatic hypermutation of the rearranged VH but not of the V-lambda gene in EBV-transformed rheumatoid factor-producing lymphoblastoid cell line.
    Chezar I; Lobel-Lavi L; Steinitz M; Laskov R
    Mol Immunol; 2008 Nov; 46(1):80-90. PubMed ID: 18718665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In a model of immunoglobulin heavy-chain (IGH)/MYC translocation, the Igh 3' regulatory region induces MYC expression at the immature stage of B cell development.
    Yan Y; Park SS; Janz S; Eckhardt LA
    Genes Chromosomes Cancer; 2007 Oct; 46(10):950-9. PubMed ID: 17639584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF-kappa B activity is required for the deregulation of c-myc expression by the immunoglobulin heavy chain enhancer.
    Kanda K; Hu HM; Zhang L; Grandchamps J; Boxer LM
    J Biol Chem; 2000 Oct; 275(41):32338-46. PubMed ID: 10931834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Richter's and prolymphocytic transformation of chronic lymphocytic leukemia are associated with high mRNA expression of activation-induced cytidine deaminase and aberrant somatic hypermutation.
    Reiniger L; Bödör C; Bognár A; Balogh Z; Csomor J; Szepesi A; Kopper L; Matolcsy A
    Leukemia; 2006 Jun; 20(6):1089-95. PubMed ID: 16541139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiimmunoglobulin inhibition of Burkitt's lymphoma cell proliferation and concurrent reduction of c-myc and mu heavy chain gene expression.
    Arasi VE; Lieberman R; Sandlund J; Kiwanuka J; Novikovs L; Kirsch I; Hollis G; Magrath IT
    Cancer Res; 1989 Jun; 49(12):3235-41. PubMed ID: 2497974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory elements in the immunoglobulin heavy chain gene 3'-enhancers induce c-myc deregulation and lymphomagenesis in murine B cells.
    Wang J; Boxer LM
    J Biol Chem; 2005 Apr; 280(13):12766-73. PubMed ID: 15687498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AID-targeting and hypermutation of non-immunoglobulin genes does not correlate with proximity to immunoglobulin genes in germinal center B cells.
    Gramlich HS; Reisbig T; Schatz DG
    PLoS One; 2012; 7(6):e39601. PubMed ID: 22768095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variable IgH chain enhancer activity in Burkitt's lymphomas suggests an additional, direct mechanism of c-myc deregulation.
    Jain VK; Judde JG; Max EE; Magrath IT
    J Immunol; 1993 Jun; 150(12):5418-28. PubMed ID: 8515068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A myeloma translocation-like model associating CCND1 with the immunoglobulin heavy-chain locus 3' enhancers does not promote by itself B-cell malignancies.
    Fiancette R; Amin R; Truffinet V; Vincent-Fabert C; Cogné N; Cogné M; Denizot Y
    Leuk Res; 2010 Aug; 34(8):1043-51. PubMed ID: 20018375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theophylline induced differentiation provides direct evidence for the deregulation of c-myc in Burkitt's lymphoma and suggests participation of immunoglobulin enhancer sequences.
    Sandlund JT; Neckers LM; Schneller HE; Woodruff LS; Magrath IT
    Cancer Res; 1993 Jan; 53(1):127-32. PubMed ID: 8416737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice.
    Park SS; Kim JS; Tessarollo L; Owens JD; Peng L; Han SS; Tae Chung S; Torrey TA; Cheung WC; Polakiewicz RD; McNeil N; Ried T; Mushinski JF; Morse HC; Janz S
    Cancer Res; 2005 Feb; 65(4):1306-15. PubMed ID: 15735016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a locus control region in the immunoglobulin heavy-chain locus that deregulates c-myc expression in plasmacytoma and Burkitt's lymphoma cells.
    Madisen L; Groudine M
    Genes Dev; 1994 Sep; 8(18):2212-26. PubMed ID: 7958890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.